Výsledky vyhledávání

Akademický článek

Isoform-specific promotion of breast cancer tumorigenicity by TBX3 involves induction of angiogenesis.

Autor: Krstic M; Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.; The Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada.; Department of Pathology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada., Hassan HM; Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.; Department of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada., Kolendowski B; Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.; The Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada.; Department of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.; Mary & John Knight Translational Ovarian Cancer Research Unit, London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada., Hague MN; The Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada., Anborgh PH; Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.; The Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada., Postenka CO; Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.; The Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada., Torchia J; Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.; The Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada.; Department of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada., Chambers AF; Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.; The Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada.; Department of Pathology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada., Tuck AB; Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada. alan.tuck@lhsc.on.ca.; The Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada. alan.tuck@lhsc.on.ca.; Department of Pathology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada. alan.tuck@lhsc.on.ca.

Publikováno v: Laboratory investigation; a journal of technical methods and pathology [Lab Invest] 2020 Mar; Vol. 100 (3), pp. 400-413. Date of Electronic Publication: 2019 Sep 30.

Zobrazit plný text záznamu

Akademický článek

TBX3 promotes progression of pre-invasive breast cancer cells by inducing EMT and directly up-regulating SLUG.

Autor: Krstic M; Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.; The Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada.; Department of Pathology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada., Kolendowski B; Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.; The Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada.; Department of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.; Mary & John Knight Translational Ovarian Cancer Research Unit, London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada., Cecchini MJ; Department of Pathology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada., Postenka CO; Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.; The Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada., Hassan HM; Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.; Department of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada., Andrews J; Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.; The Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada., MacMillan CD; Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada., Williams KC; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada., Leong HS; Departments of Urology, Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA., Brackstone M; Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada., Torchia J; Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.; The Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada.; Department of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada., Chambers AF; Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.; The Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada.; Department of Pathology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada., Tuck AB; Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.; The Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada.; Department of Pathology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.

Publikováno v: The Journal of pathology [J Pathol] 2019 Jun; Vol. 248 (2), pp. 191-203. Date of Electronic Publication: 2019 Apr 08.

Zobrazit plný text záznamu

Akademický článek

The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer.

Autor: Krstic M; Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.; The Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada.; Department of Pathology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada., Macmillan CD; Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.; The Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada.; Department of Pathology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada., Leong HS; Department of Surgery, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada., Clifford AG; Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.; The Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada.; Department of Pathology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada., Souter LH; Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.; The Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada.; Department of Pathology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada., Dales DW; Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.; The Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada., Postenka CO; Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.; The Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada., Chambers AF; Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.; The Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada.; Department of Pathology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada., Tuck AB; Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada. alan.tuck@lhsc.on.ca.; The Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit, London Regional Cancer Program, London Health Sciences Centre, London, ON, Canada. alan.tuck@lhsc.on.ca.; Department of Pathology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada. alan.tuck@lhsc.on.ca.

Publikováno v: BMC cancer [BMC Cancer] 2016 Aug 23; Vol. 16 (1), pp. 671. Date of Electronic Publication: 2016 Aug 23.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání